New technology vaccine to treat malaria
BioNTech decides to develop the treatment of malaria by mRNA technology-based vaccine. BioNTech is the company that developed the COVID-19 vaccine with Pfizer. It will clinically t
Sanniah Hassan

BioNTech decides to develop the treatment of malaria by mRNA technology-based vaccine. BioNTech is the company that developed the COVID-19 vaccine with Pfizer. It will clinically test the mRNA technology-based malaria vaccine by the end of 2022. This company is exploring vaccine production in Africa to enhance the manufacturing capacity and to ease global access to the vaccine.
Sanniah Hassan
JournalistStaff correspondent covering Technology and national affairs for Pakistan Times Today.
Comments (0)
No comments yet. Be the first to share your thoughts.